title: Long-term effects of two principally different antidepressant drugs on saliva secretion and composition.
abstract: In a double-blind, controlled, cross-over trial on 10 healthy volunteers, the effects of daily doses of maprotiline (75 mg) and zimelidine (100 mg) over a 14-day period were tested on saliva secretion rate and saliva composition. Based on current knowledge of salivary gland physiology and the difference in specificity between the two drugs, differences in salivary gland response could be expected. Since both drugs have anticholinergic effects which influence saliva secretion rate, the measured component concentrations had to be recalculated with regard to dependencies of secretion rate. Maprotiline, but not zimelidine, caused strong inhibition of secretion rate and accommodation ability. Maprotiline consistently caused around 50% increases in concentrations of the following saliva components: protein, amylase, fucose, hexose, sialic acid and potassium. The effects of zimelidine were less pronounced and resulted in initial increases of most organic components. 14 and 18 h after the intake of the drug these increases had disappeared and some of the components instead showed decreased concentrations. The results are consistent with current theories about facilitated serotoninergic and noradrenergic transmissions during treatment with antidepressants.
mesh_terms: D000042:Absorption; D000328:Adult; D000873:Anthracenes / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008376:Maprotiline / Q000378:metabolism / Q000494:pharmacology*; D012463:Saliva / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D013997:Time Factors; D015031:Zimeldine / Q000378:metabolism / Q000494:pharmacology*
chemical_list: D000873:Anthracenes; D008376:Maprotiline; D015031:Zimeldine